INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 54 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $307,000 | -31.2% | 573,217 | -1.2% | 0.00% | – |
| Q4 2017 | $446,000 | -46.6% | 579,957 | +0.6% | 0.00% | – |
| Q3 2017 | $835,000 | -47.1% | 576,241 | -1.3% | 0.00% | – |
| Q2 2017 | $1,577,000 | -80.1% | 583,793 | -70.1% | 0.00% | – |
| Q1 2017 | $7,916,000 | +79060.0% | 1,954,322 | +85540.8% | 0.00% | – |
| Q4 2016 | $10,000 | -33.3% | 2,282 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | +36.4% | 2,282 | +25.5% | 0.00% | – |
| Q2 2016 | $11,000 | -15.4% | 1,818 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | +160.0% | 1,818 | +175.9% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 659 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -45.5% | 659 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | – | 659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|